Evaluation of effectiveness of palliative radiotherapy for bone metastases: a prospective cohort study
Open Access
- 10 November 2018
- journal article
- research article
- Published by Springer Nature in Journal of Radiation Oncology
- Vol. 7 (4) , 325-333
Abstract
Objective Radiotherapy is the standard local treatment for patients with painful bone metastases, but effectiveness has primarily been evaluated in trial populations. The aim of this study was to study pain response to palliative radiotherapy in a prospective cohort of unselected patients with bone metastases. Methods Patients with painful bone metastases referred to the UMC Utrecht for radiotherapy and enrolled in the PRESENT cohort were included in this study. For all patients, pain response to radiotherapy was assessed, and responders were defined as patients with a complete or partial pain response. Patients with stable pain scores, pain increase, or undetermined response were regarded non-responders. Pain scores obtained at baseline and after 2, 4, 6, 8, and 12 weeks following radiotherapy were obtained. Pain response rates of the total treated population, as well as response rates of the assessable patients, were calculated. To measure the percentage of the remaining time spent with pain relief, the net pain relief (NPR) was calculated by dividing the period of pain relief by the period of survival. Results Of the 432 patients enrolled in this study, 262 patients (61%) experienced a complete or partial response. In the 390 assessable patients, this percentage was 67%. Median time to response was 4 weeks (range 1–15 weeks), and the NPR was 64%. Conclusion Compared to randomized trial populations, palliative radiotherapy in our unselected patients with bone metastases showed similar pain response rates (61%), with a reasonable duration of this effect.Keywords
Funding Information
- University Medical Center Utrecht
This publication has 30 references indexed in Scilit:
- Update of the International Consensus on Palliative Radiotherapy Endpoints for Future Clinical Trials in Bone MetastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1–2 trialThe Lancet Oncology, 2012
- Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" designBMJ, 2010
- When Should we Define the Response Rates in the Treatment of Bone Metastases by Palliative Radiotherapy?Clinical Oncology, 2008
- Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical JournalsJAMA, 2007
- The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative careEuropean Journal of Cancer, 2006
- Prediction of survival in patients with metastases in the spinal columnCancer, 2005
- Adjuvant Analgesics in Cancer Pain ManagementThe Oncologist, 2004
- Palliation of metastatic bone pain: single fraction versus multifraction radiotherapyCochrane Database of Systematic Reviews, 2002
- The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis StudyRadiotherapy and Oncology, 1999